
xbird is an AI-powered healthcare company focused on improving the lives of people with Type 2 diabetes. Their product leverages advanced artificial intelligence and machine learning models to analyze sensor data from smartphones and wearables, understanding the relationship between a patient's behavior, therapy, and medical conditions. This enables personalized support for existing therapies, with a three-step process: capturing around-the-clock sensor data, evaluating behavioral patterns with medical-grade accuracy using convolutional neural networks, and alerting patients with personalized notifications and recommendations when they need support most. The company's infrastructure is certified to pass the highest level of medical scrutiny. xbird offers an SDK for seamless integration with existing apps, available for iOS and Android, with efficient power usage and a small bandwidth footprint. They are committed to data protection, compliant with ISO 27001, and in the process of obtaining MDR certifications.

xbird is an AI-powered healthcare company focused on improving the lives of people with Type 2 diabetes. Their product leverages advanced artificial intelligence and machine learning models to analyze sensor data from smartphones and wearables, understanding the relationship between a patient's behavior, therapy, and medical conditions. This enables personalized support for existing therapies, with a three-step process: capturing around-the-clock sensor data, evaluating behavioral patterns with medical-grade accuracy using convolutional neural networks, and alerting patients with personalized notifications and recommendations when they need support most. The company's infrastructure is certified to pass the highest level of medical scrutiny. xbird offers an SDK for seamless integration with existing apps, available for iOS and Android, with efficient power usage and a small bandwidth footprint. They are committed to data protection, compliant with ISO 27001, and in the process of obtaining MDR certifications.
Focus: AI-powered personalization for people with Type 2 diabetes
Product: Sensor- and smartphone-driven SDK and platform (iOS & Android) for continuous monitoring and personalized notifications
Founded / HQ: 2015, Berlin, Germany
Security & Reg: ISO 27001 compliant; pursuing MDR certification
Funding signal: Three disclosed funding rounds; last disclosed event Jun 10, 2016; investors include VentureOut and Cascara Ventures
Diabetes therapy personalization and chronic disease support using sensor data and AI
2015
Healthcare / Medical AI
Most-recent disclosed funding event per available records
Documented investor listed in company profiles
“Recorded investors include VentureOut, Cascara Ventures, and Jens Hilgers; company records show three disclosed funding rounds and a later acquisition event”